Feasibility of a Day-Camp Model of Modified Constraint-Induced Movement Therapy with and without Botulinum Toxin A Injection for Children with Hemiplegia

Eliasson, A-C., Shaw, K., Ponten, E., Boyd, R. and Krumlinde-Sundholm, L. (2009) Feasibility of a Day-Camp Model of Modified Constraint-Induced Movement Therapy with and without Botulinum Toxin A Injection for Children with Hemiplegia. Physical & Occupational Therapy in Pediatrics, 29 3: 311-332. doi:10.1080/01942630903011123


Author Eliasson, A-C.
Shaw, K.
Ponten, E.
Boyd, R.
Krumlinde-Sundholm, L.
Title Feasibility of a Day-Camp Model of Modified Constraint-Induced Movement Therapy with and without Botulinum Toxin A Injection for Children with Hemiplegia
Journal name Physical & Occupational Therapy in Pediatrics   Check publisher's open access policy
ISSN 0194-2638
Publication date 2009-01-01
Year available 2009
Sub-type Article (original research)
DOI 10.1080/01942630903011123
Volume 29
Issue 3
Start page 311
End page 332
Total pages 22
Editor Majnemer, A.
Palisano, R. J.
Place of publication United States of America
Publisher Informa Healthcare
Language eng
Subject C1
920201 Allied Health Therapies (excl. Mental Health Services)
920501 Child Health
920111 Nervous System and Disorders
111403 Paediatrics
111703 Care for Disabled
Abstract The objective of the study was to investigate the feasibility of modified constraint-induced (CI) therapy provided in a 2-week day-camp model with and without intramuscular botulinum toxin type A (BoNT-A) injections for children with congenital cerebral palsy. Sixteen children with congenital hemiplegia, Manual Ability Classification System (MACS) level I and II, aged 8-17 years, participated in a CI therapy day camp; of whom five participants (aged 11-16 years) received intramuscular BoNT-A prior to CI therapy. Assessments were conducted 4 months and 2 weeks before (baselines 1 and 2), immediately after, and 6 months after the day camp. For the children who received BoNT-A, no statistical analyses were conducted due to the small size of the sample. In this group, consistent improvement was only found according to the Melbourne Unilateral Limb Assessment. The children who received only the CI therapy demonstrated improvements in the Jebsen-Taylor Hand Function Test (p = .04) at posttest, but improvements were not sustained at 6-month follow-up. No significant improvement was obtained for the Melbourne Assessment or the Assisting Hand Assessment. Children in both groups improved on specially trained tasks: frisbee golf, stacking blocks, and in-hand manipulation. Feedback from the participants suggests that the day-camp model is a feasible intervention following intramuscular BoNT-A injections. The results suggest that children with congenital hemiplegia with varying severity of impairment in hand function may benefit from CI therapy, but not every child demonstrates improvements in hand function. The characteristics of children who respond the best to CI therapy are not clear
Keyword Botulinum toxin A
upper extremity
hemiplegia
hand function
group therapy
constraint-induced movement therapy
Q-Index Code C1
Q-Index Status Confirmed Code

Document type: Journal Article
Sub-type: Article (original research)
Collection: 2010 Higher Education Research Data Collection
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 22 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 23 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 22 Mar 2010, 20:28:21 EST by Maree Knight on behalf of Mater Clinical School